Dare Bioscience, Inc. Operating Lease Liability
Dare Bioscience, Inc. (DARE) had Operating Lease Liability of $868.37 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability $868.37K.
- 2026-03-31: Operating Lease, Liability $1.02M.
- 2025-12-31: Operating Lease, Liability $1.16M.
- 2025-09-30: Operating Lease, Liability $898.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $868.37K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.02M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.16M 10-K · filed 2026-03-26 |
| 2025-09-30 | $898.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.04M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.17M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.30M 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.40M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.52M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.64M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.41M 10-K · filed 2024-03-28 |
| 2023-09-30 | $195.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $296.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $393.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $489.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $583.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.15M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.21M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $270.50K 10-K · filed 2022-03-31 |
| 2021-09-30 | $384.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $492.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $596.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $389.00K 10-K · filed 2021-03-30 |
| 2020-09-30 | $493.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $592.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $689.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $800.00K 10-K · filed 2020-03-27 |
| 2019-09-30 | $183.20K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $193.40K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $223.04K 10-Q · filed 2019-05-14 |
| 2019-01-01 | $241.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |